NAT Diagnostics, Inc. — Form D
NAT Diagnostics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-16. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-16
- Form: D
- Accession: 0001640306-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Minimum investment: $12K
- Investors: 18
- Date of first sale: 2017-11-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298932
Issuer
- Name: NAT Diagnostics, Inc.
- CIK: 0001640306
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11585 Sorrento Valley Rd., Ste. 107, SAN DIEGO, CA, 92121
- Phone: (858) 531-3129
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Allan J Fan | Director | San Diego, CA |
| David J Galas | Director | San Diego, CA |
| Andrew P Miller | Director | San Diego, CA |
| Thomas J Wu | Director | San Diego, CA |
| Andrew P Miller | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More